🍽️ bromhexine hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Respiratory Conditions: Bromhexine hydrochloride is commonly used to alleviate symptoms associated with respiratory conditions such as acute and chronic bronchitis, asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), and other respiratory tract infections. It helps in thinning and loosening mucus, making it easier to cough up and clear the airways.

  2. Productive Cough: Bromhexine hydrochloride is particularly effective in relieving productive coughs (coughs that produce mucus or phlegm) by increasing the volume and reducing the viscosity of respiratory secretions, thereby facilitating their removal from the airways.

  3. Mucus Clearance: By enhancing the activity of specialized cells in the respiratory tract known as ciliated epithelial cells, bromhexine hydrochloride promotes mucociliary clearance, which is the process by which mucus and foreign particles are moved out of the respiratory tract via the coordinated beating of cilia.

  4. Chronic Respiratory Disorders: Patients with chronic respiratory disorders, such as COPD and bronchiectasis, may benefit from bromhexine hydrochloride therapy to alleviate symptoms related to excessive mucus production and impaired mucus clearance.

  5. Post-Operative Respiratory Care: Bromhexine hydrochloride may be used as part of post-operative respiratory care to prevent complications such as atelectasis (collapsed lung) and pneumonia by facilitating the clearance of mucus from the airways, particularly in patients who are immobilized or have difficulty coughing effectively.

  6. Cystic Fibrosis: Bromhexine hydrochloride may be used as an adjunctive treatment in patients with cystic fibrosis, a genetic disorder characterized by the production of thick, sticky mucus that can obstruct the airways and lead to recurrent respiratory infections. Bromhexine hydrochloride helps in thinning the mucus, making it easier to clear from the lungs.

  7. Side Effects: Common side effects of bromhexine hydrochloride may include nausea, vomiting, diarrhea, abdominal pain, and skin rashes. These side effects are usually mild and transient.

  8. Contraindications: Bromhexine hydrochloride is contraindicated in individuals with a history of hypersensitivity to the medication or its components. It should be used with caution in patients with peptic ulcer disease, severe liver impairment, or renal insufficiency.

  9. Drug Interactions: Bromhexine hydrochloride may interact with certain medications, including antitussives (cough suppressants) and mucolytics, potentially altering their effectiveness or increasing the risk of side effects. It's important for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting bromhexine hydrochloride therapy.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of bromhexine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces

Bacteria Impacted by bromhexine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Agathobacter genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Ruminococcus genus Decreases 👪 Source Study
Akkermansia genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Roseburia intestinalis species Decreases 📓 Source Study
Coprococcus comes species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Ruminococcus bromii species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Akkermansia muciniphila species Decreases 📓 Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of bromhexine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.9 0.2 3.5
Age-Related Macular Degeneration and Glaucoma 0.2 0.1 1
Allergic Rhinitis (Hay Fever) 0.1 0.1
Allergies 0.3 -0.3
Allergy to milk products 0.1 0.1 0
Alopecia (Hair Loss) 0.3 0.3
Alzheimer's disease 0.3 2 -5.67
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.1 0.2 4.5
Ankylosing spondylitis 0.3 0.5 -0.67
Anorexia Nervosa 0.1 1.1 -10
Antiphospholipid syndrome (APS) 0.5 0.5
Asthma 0.4 -0.4
Atherosclerosis 0.1 0.8 -7
Atrial fibrillation 1.2 0.1 11
Autism 0.9 2.8 -2.11
Barrett esophagus cancer 0 0
Bipolar Disorder 0.2 0.5 -1.5
Brain Trauma 0.2 -0.2
Carcinoma 0.3 0.2 0.5
Celiac Disease 0 0.7 0
Cerebral Palsy 0.1 0.3 -2
Chronic Fatigue Syndrome 0.5 1.6 -2.2
Chronic Kidney Disease 0.1 1.5 -14
Chronic Lyme 0.2 -0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.1 0.8 -7
Chronic Urticaria (Hives) 0 0.1 0
Coagulation / Micro clot triggering bacteria 0.2 0.4 -1
Colorectal Cancer 0.6 0.4 0.5
Constipation 0.4 0.2 1
Coronary artery disease 0.5 0.2 1.5
COVID-19 0.4 3.4 -7.5
Crohn's Disease 0.7 2.6 -2.71
cystic fibrosis 0.2 -0.2
deep vein thrombosis 0.4 -0.4
Depression 1.5 2.4 -0.6
Dermatomyositis 0 0
Eczema 0.1 -0.1
Endometriosis 0.4 0.5 -0.25
Epilepsy 0.1 0.3 -2
Fibromyalgia 0.4 0.4 0
Functional constipation / chronic idiopathic constipation 1.1 0.4 1.75
gallstone disease (gsd) 0.2 0.2 0
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0 0
Generalized anxiety disorder 0.2 -0.2
Glioblastoma 0 0
Gout 0.2 -0.2
Graves' disease 0.1 0.2 -1
Halitosis 0 0
Hashimoto's thyroiditis 0.3 0.3
Hidradenitis Suppurativa 0 0
hypercholesterolemia (High Cholesterol) 0.1 -0.1
hyperglycemia 0.3 -0.3
Hyperlipidemia (High Blood Fats) 0.1 0.1
hypertension (High Blood Pressure 0.4 0.5 -0.25
Hypothyroidism 0.2 -0.2
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0.7 -0.7
Inflammatory Bowel Disease 0.1 3.2 -31
Insomnia 0 0.6 0
Intelligence 0.2 0.2
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 0.5 0.9 -0.8
Liver Cirrhosis 0.8 0.6 0.33
Long COVID 1.4 2.4 -0.71
Low bone mineral density 0.8 -0.8
Lung Cancer 0.2 -0.2
Mast Cell Issues / mastitis 0 0.3 0
ME/CFS with IBS 0 0.4 0
ME/CFS without IBS 0.2 0.3 -0.5
Metabolic Syndrome 0.8 0.9 -0.13
Mood Disorders 1.9 2.4 -0.26
multiple chemical sensitivity [MCS] 0.2 0.2
Multiple Sclerosis 0.6 2.3 -2.83
Multiple system atrophy (MSA) 0.2 0.1 1
neuropathic pain 0.4 -0.4
Neuropathy (all types) 0.1 0.1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0 1.5 0
Obesity 0.8 0.7 0.14
obsessive-compulsive disorder 0.8 0.7 0.14
Osteoarthritis 0 0.1 0
Osteoporosis 0.1 0.1 0
pancreatic cancer 0 0
Parkinson's Disease 0.6 1.8 -2
Polycystic ovary syndrome 0.2 0.5 -1.5
Postural orthostatic tachycardia syndrome 0.2 -0.2
Premenstrual dysphoric disorder 0.1 -0.1
Psoriasis 0.2 1 -4
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.1 0.4 1.75
Rosacea 0.1 0.2 -1
Schizophrenia 0.9 0.5 0.8
scoliosis 0.2 0.8 -3
Sjögren syndrome 0.2 0.5 -1.5
Sleep Apnea 0.3 0.4 -0.33
Small Intestinal Bacterial Overgrowth (SIBO) 0 0
Stress / posttraumatic stress disorder 0.4 0.5 -0.25
Systemic Lupus Erythematosus 0.4 0.7 -0.75
Tic Disorder 0.1 0.1
Tourette syndrome 0.1 0.1
Type 1 Diabetes 0.3 0.7 -1.33
Type 2 Diabetes 0.8 0.9 -0.13
Ulcerative colitis 0 0.8 0
Unhealthy Ageing 0.2 1.2 -5

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [44.222.64 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.222.64 ]